Landscapes / Targets
IL-4Rα
5 drugs act on IL-4Rα, in 37 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Artificial immunoglobulin |
Approved in China | Dec 2026Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Atopic Dermatitis, Seasonal Allergic Rhinitis (SAR) and 3 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Regeneron +1 · Public REGN · SNY |
Approved | 7 Feb 2027Phase 4 trial completes | ||
| How it works | An antibody | ||||
| Next date | 7 Feb 2027 · Phase 4 trial completes | ||||
| Also tested for | Asthma, Dermatitis Atopic and 14 more | ||||
| Open drug page | |||||
— |
Phase 3 | 5 Jan 2027Phase 3 trial completes | |||
| Next date | 5 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Atopic Dermatitis, Prurigo Nodularis and 7 more | ||||
| Open drug page | |||||
— |
Phase 3 | 15 May 2027Phase 3 trial completes | |||
| Next date | 15 May 2027 · Phase 3 trial completes | ||||
| Also tested for | Allergic Rhinitis, Seasonal, Allergic Rhinitis | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Seasonal Allergic Rhinitis | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026